ArticleOncoTargets and therapy2017

Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents.

Nehad M Ayoub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.